The same visceral fat that drives metabolic disease also converts testosterone to estrogen through an enzyme called aromatase
Both drug classes were equally effective in reducing combined major adverse cardiac events such as heart attack, stroke, and death from cardiovascular disease, compared to people with diabetes who were not taking the drugs.[3] The rate of hospitalization for heart failure was 32% less in patients taking SGLT2 inhibitors compared to patients not taking the drugs, especially in those with more severe cardiovascular disease risk
For this reason, we encourage our patients to achieve a body mass index (BMI) of less than 35, and if possible, less than 30
Is Noom Med a legitimate GLP-1 provider
Whether it pays off in the populations not yet read out type 2 diabetes (TRIUMPH-2), sleep apnea (TRIUMPH-3), cardiovascular outcomes (TRIUMPH-CVOT) is the next set of questions